Cobalamin intake and related biomarkers: examining associations with mortality risk among adults with type 2 diabetes in NHANES
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed the therapeutic landscape of type 2 diabetes (T2D) and obesity by offering substantial weight loss and cardiometabolic protection
doi:10.1155/2021/6564585 [Made by author on BioRender] The interactions of these different cell types together with efficient junctions and the multilayer structure ensure protection of the brain from harmful substances
In 2013, Gipg013, a GIP receptor immunoglobin G antibody, was presented
Hims & Hers has sold weight-loss drugs for years in injection form, which is the most commonly available way to receive the medication and was, for a long time, the only way
The FDA Adverse Event Reporting System (FAERS) is a comprehensive database of ADRs specifically designed by the FDA to facilitate postmarketing surveillance of drugs and therapeutic biologics [19]